Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine.

1. To investigate the interaction of angiotensin-converting-enzyme (ACE) inhibitor and calcium antagonist, we conducted a double-blind randomized, placebo-controlled crossover study of a new ACE inhibitor (CGS 14824 A, 20 mg) during intravenous administration (i.v.) of nicardipine in eight normotens...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bellet, M, Sassano, P, Guyenne, T, Corvol, P, Menard, J
Formato: Artigo
Idioma:Inglês
Publicado: 1987
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1386308/
https://ncbi.nlm.nih.gov/pubmed/3689627
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares